Ronald C. Renaud Jr.

Companies

• Kailera Therapeutics, Inc.Board member Apr 16, 2026 to now¹
• Kailera Therapeutics, Inc.Chief executive officer Apr 16, 2026 to now¹
• Kailera Therapeutics, Inc.President Apr 16, 2026 to now¹
• Upstream Bio, Inc.Board member Oct 10, 2024 to now²
• Cerevel Therapeutics Holdings, Inc.Board member Jun 14, 2023 to Aug 5, 2024³
• Cerevel Therapeutics Holdings, Inc.Chief executive officer Jun 14, 2023 to Aug 5, 2024³
• Cerevel Therapeutics Holdings, Inc.President Jun 14, 2023 to Aug 5, 2024³
• Atara Biotherapeutics, Inc.Board member Apr 30, 2020 to Jun 27, 2022⁴
• ImageneBio, Inc.Board member Mar 25, 2021 to Jun 13, 2022⁵
• Chimerix (United States)Board member Dec 18, 2014 to Jun 24, 2019⁶
• Akebia Therapeutics, Inc.Board member Sep 15, 2014 to Jun 15, 2018⁷
• PTC TherapeuticsBoard member Jun 11, 2014 to Jan 5, 2017⁸

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKailera Therapeutics, Inc. KLRA38,094 shares⁹$440.0K at $11.55Jun 9, 2026
• ABAtara Biotherapeutics, Inc. ATRA31,500 shares¹⁰$291.1K at $9.24Jun 23, 2022
• CTCerevel Therapeutics Holdings, Inc.0 shares¹¹Aug 1, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 9, 2026Exercised options 38,094 shares at $5.25 of Kailera Therapeutics, Inc.⁹
• Aug 1, 2024Returned to company 83,857 shares of Cerevel Therapeutics Holdings, Inc.¹¹
• Aug 1, 2024Returned to company 160,452 shares of Cerevel Therapeutics Holdings, Inc.¹¹
• Dec 19, 2023Exercised options 160,452 shares of Cerevel Therapeutics Holdings, Inc.¹²
• Aug 3, 2023Bought 83,857 shares at $23.96 of Cerevel Therapeutics Holdings, Inc.¹³
• Jun 23, 2022Granted 20,500 shares of Atara Biotherapeutics, Inc.¹⁰